Alembic Pharmaceutical - Q1FY2014 Result Preview - Angel Broking

Alembic Pharmaceutical, is expected to register a strong revenue growth of 18.6%. Its OPM is expected to expand by 139bp during the period to end at 15.7%, on account of which, the net profit will increase by around 50.6% for the quarter. We maintain our neutral stance on the stock.

Source : Equity Bulls

Keywords